Ularitide

CAS No: 118812-69-4

Purity: 95%

Molar Mass: 3505.96

Chemical Formula: C145H234N52O44S3

* Please kindly note that our products are not to be used for therapeutic purposes and cannot be sold to patients.

Product Name: Ularitide

CAS No: 118812-69-4

Purity: 95%

Molar Mass: 3505.96

Chemical Formula: C145H234N52O44S3

Synonyms: Urodilatin

Storage: Store at -20℃

Sequence: TAPRSLRRSSCFGGRMDRIGAQSGLGCNSFRY

Target: renal receptors

Application: Ularitide (CAS: 118812-69-4) is a synthetic form of urodilatin, a natriuretic peptide primarily synthesized in the kidney. It functions as a vasodilator and natriuretic hormone, playing a key role in regulating blood pressure and fluid balance in the body. Ularitide acts by stimulating guanylate cyclase receptors in the vascular smooth muscle and renal tubules, leading to increased cyclic guanosine monophosphate (cGMP) levels, which in turn promote vasodilation and natriuresis (excretion of sodium in urine). Due to its potent vasodilatory and diuretic effects, ularitide is being investigated for its potential therapeutic applications in conditions such as acute decompensated heart failure (ADHF). Clinical trials have shown promising results, demonstrating ularitide’s ability to improve hemodynamic parameters, relieve symptoms, and reduce hospitalizations in patients with ADHF. Despite these positive findings, further research is needed to fully elucidate ularitide’s mechanisms of action and optimize its clinical use in heart failure management.

Reference:

Gantzel, R. H., Meyer, M., Mazgareanu, S., Aagaard, N. K., Jepsen, P., Holzmeister, J., … & Grnbk, H. (2021). Ularitide as treatment of refractory ascites in cirrhosis-a study protocol for a randomised trial.Danish Medical Journal,68(12), A07210610.

Emani, S., Meyer, M., Palm, D., Holzmeister, J., & Haas, G. J. (2015). Ularitide: a natriuretic peptide candidate for the treatment of acutely decompensated heart failure. Future Cardiology, 11(5), 531-546.